Published in Cancer Weekly, October 31st, 2006
Researchers in the United States conducted a study "to compare the pharmacologic profile of fulvestrant with that of tamoxifen and the aromatase inhibitors with respect to the choice of treatment for ABC. Principal literature and review articles were obtained from MEDLINE (1991-March 2006)."
"Key search terms included fulvestrant, tamoxifen, aromatase inhibitors, pharmacology, and breast cancer," explained A.U. Buzdar and colleagues, M.D. Anderson Cancer Center. "Further data sources were identified from the bibliographies of selected articles....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.